Iridex (IRIX) Liabilities and Shareholders Equity (2016 - 2026)
Iridex has reported Liabilities and Shareholders Equity over the past 16 years, most recently at $29.2 million for Q1 2026.
- For Q1 2026, Liabilities and Shareholders Equity changed 0.05% year-over-year to $29.2 million; the TTM value through Jan 2026 reached $123.3 million, down 1.05%, while the annual FY2026 figure was $29.2 million, 0.05% changed from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 was $29.2 million at Iridex, up from $28.4 million in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $48.7 million in Q1 2022 and troughed at $28.4 million in Q3 2025.
- A 5-year average of $36.8 million and a median of $34.4 million in 2023 define the central range for Liabilities and Shareholders Equity.
- Biggest five-year swings in Liabilities and Shareholders Equity: skyrocketed 74.07% in 2022 and later fell 22.26% in 2023.
- Year by year, Liabilities and Shareholders Equity stood at $42.3 million in 2022, then fell by 18.57% to $34.4 million in 2023, then dropped by 15.39% to $29.1 million in 2024, then decreased by 2.68% to $28.4 million in 2025, then rose by 2.81% to $29.2 million in 2026.
- Business Quant data shows Liabilities and Shareholders Equity for IRIX at $29.2 million in Q1 2026, $28.4 million in Q3 2025, and $31.6 million in Q2 2025.